Report Categories
View AllRecent Articles
View All
FENC Fennec Pharmaceuticals posts far wider than expected Q4 2025 loss even as shares tick higher
The credit profile of BioGreen Med BGMS revealed Q3 2024 EPS Beats Forecasts
How Illumina ILMN performance reflects its true potential Slight Loss 20260508
COMP Compass delivers narrower Q4 2025 loss than analyst estimates shares slide 238 percent today